The long and the short of it is that healthcare stocks can offer long and short-term returns, writes Kristine Bryan
The fact that people are living longer, coupled with the need for more treatments for more diseases, makes healthcare one of the fastest growing industries in the developed world. Medical companies are constantly trying to find new ways of administering established drugs in a more patient-friendly way. An example of this is the discovery of inhaled insulin by Pfizer, Inhale Therapeutics and Aventis, which should allow many diabetics to avoid or reduce the painful regime of having to inject themselves several times each day. In addition, the fact that more people can now afford a wider...
To continue reading this article...
Join Professional Adviser for free
- Unlimited access to real-time news, industry insights and market intelligence
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters
- Make smart business decisions with the latest developments in regulation, investing retirement and protection
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes